Details

Autor(en) / Beteiligte

• Ilyas, M.
• Colegio, O. R.
• Kaplan, B.
• Sharma, A.

Titel

Cutaneous Toxicities From Transplantation‐Related Medications

Ist Teil von

• American journal of transplantation, 2017-11, Vol.17 (11), p.2782-2789

Ort / Verlag

United States: Wiley Subscription Services, Inc

Erscheinungsjahr

2017

Quelle

Wiley Online Library All Journals

Beschreibungen/Notizen

• Despite the abundance of information on cutaneous malignancies associated with solid organ transplantation in the transplant literature, there is limited information regarding nonmalignant skin changes after transplantation. There are numerous skin toxicities secondary to immunosuppressive and other transplant‐related medications that can vary in presentation, severity, and prognosis. To limit associated morbidity and mortality, solid organ transplant recipient care providers should effectively identify and manage cutaneous manifestations secondary to drug toxicity. Toxicities from the following transplant‐related medications will be discussed: antithymocyte globulins, systemic steroids, cyclosporine, tacrolimus, azathioprine, mycophenolate mofetil, mammalian target of rapamycin inhibitors sirolimus and everolimus, basiliximab and daclizumab, belatacept, and voriconazole. The authors review cutaneous toxicities caused by transplant‐related medications in solid organ transplant recipients.